The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen -
How VA is Using Digital Services to Expand Care to Veterans
CIO Kurt DelBene says the the agency’s 2024 priorities included AI adoption, hiring and a better user experience for veterans.
30m listen -
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
In this episode, Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen